Start Date: May 29, 2018
End Date: May 30, 2018
Ethical and regulatory parameters lay a special emphasis on animal modeling to carry forward the researches over tissue engineering and organ transplantation. This is one of the major challenge being faced for the clinical applications of regenerative medicine.
The translational research promises to improvise a structural shift in healthcare by focusing on the underlying causes of disease by repairing, replacing, or regenerating damaged cells in the body. The conference aims on the similar lines to assess these risks and benefits of regenerative medicine through the application of cellular therapies, stem cells and biocompatible materials.
MarketsandMarkets has put together a platform for the leading experts of industry to discuss strategies, technologies and innovations in tissue engineering & biomaterials, cellular therapies and diagnosis of regenerative medicines at the Next-Gen Regenerative Medicine & Tissue Engineering Conference scheduled to be held on 29th-30th May, 2018, Frankfurt, Germany.